scholarly journals Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non-small cell lung cancer

2017 ◽  
Vol 79 (3) ◽  
pp. 489-495 ◽  
Author(s):  
Toshio Shimizu ◽  
Kimio Yonesaka ◽  
Hidetoshi Hayashi ◽  
Tsutomu Iwasa ◽  
Koji Haratani ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Monoclonal Antibody ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 1 Study ◽  
New Formulation

scholarly journals Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non–Small-Cell Lung Cancer

2019 ◽  
Vol 20 (3) ◽  
pp. e317-e328 ◽  
Author(s):  
Hiroshi Nokihara ◽  
Makoto Nishio ◽  
Noboru Yamamoto ◽  
Yutaka Fujiwara ◽  
Hidehito Horinouchi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Japanese Patients ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 1 Study

A phase 1 study evaluating the safety and efficacy of DKN-01, an investigational monoclonal antibody (Mab) in patients (pts) with advanced non-small cell lung cancer.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 8068-8068 ◽  
Author(s):  
William Jeffery Edenfield ◽  
Donald A. Richards ◽  
Svetislava J. Vukelja ◽  
Glen J. Weiss ◽  
Cynthia A. Sirard ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Monoclonal Antibody ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 1 Study ◽  
Safety And Efficacy

scholarly journals Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer

2013 ◽  
Vol 109 (3) ◽  
pp. 538-544 ◽  
Author(s):  
M Nishio ◽  
T Horai ◽  
A Horiike ◽  
H Nokihara ◽  
N Yamamoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase 1 ◽  
Small Cell ◽  
Small Cell Lung ◽  
Phase 1 Study
Sign in / Sign up

Export Citation Format

Share Document